/newsroom/taxonomy/term/3734/all en /newsroom/channels/news/study-sheds-light-how-immune-system-protects-body-348205 <p>First <a href="https://doi.org/10.1016/j.cell.2022.12.038">study</a> of humans with a rare immunodeficiency reveals how the immune system protects the body against pathogens known to cause serious diseases, such as tuberculosis and COVID-19. The research involving 黑料不打烊 University, paves the way for new therapies to treat autoimmune diseases, chronic inflammatory diseases, and new approaches to vaccine development.</p> Fri, 05 May 2023 18:41:23 +0000 shirley.cardenas@mcgill.ca 299312 at /newsroom /newsroom/channels/news/new-study-uncovers-vast-variation-and-significant-deficits-tuberculosis-care-urban-india-290004 <p>On September 26, Heads of State will gather in New York at the United Nations (UN) General Assembly鈥檚 first-ever high-level meeting on tuberculosis (TB) to accelerate efforts to end TB and reach all affected people with prevention and care.</p> Tue, 25 Sep 2018 18:12:59 +0000 justin.dupuis@mcgill.ca 85035 at /newsroom /newsroom/channels/news/complete-make-over-fight-multidrug-resistant-tuberculosis-289423 <p>Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study led by Dr. Dick Menzies, senior scientist at the Research Institute of the 黑料不打烊 University Health Centre (RI-MUHC) in Montreal. These findings precipitated a complete overhaul of worldwide TB treatment guidelines, with the results of this work published today in the British medical journal <i>The Lancet</i>.</p> Fri, 07 Sep 2018 19:59:02 +0000 justin.dupuis@mcgill.ca 81061 at /newsroom /newsroom/channels/news/latent-tb-treatment-shorter-better-288462 <p>Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the 黑料不打烊 University Health Centre (RI-MUHC) revealed that a shorter treatment was safer and more effective in children and adults compared to the current standard. These findings are published today in the New England Journal of Medicine.</p> Thu, 02 Aug 2018 13:38:58 +0000 cynthia.lee@mcgill.ca 66316 at /newsroom /newsroom/channels/news/beyond-killing-tuberculosis-287156 <p>Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease. However, this perspective has recently been challenged as scientists have taken a lesson from plant biologists about an ancient strategy involving the ability to 鈥渢olerate鈥� rather than 鈥渞esist鈥� infection to maintain health. This concept, referred to as 鈥渄isease tolerance鈥�, provides an opportunity to develop new strategies that mitigate the consequences of infection.</p> Fri, 11 May 2018 19:03:57 +0000 justin.dupuis@mcgill.ca 39879 at /newsroom /newsroom/channels/news/re-programming-innate-immune-cells-fight-tuberculosis-283809 <p align="center"> Thu, 11 Jan 2018 15:59:57 +0000 mona.noonoo@mail.mcgill.ca 32828 at /newsroom /newsroom/channels/news/new-muhc-study-calls-targeted-screening-high-risk-healthcare-workers-tuberculosis-269175 <p> Mon, 31 Jul 2017 17:48:51 +0000 cynthia.lee@mcgill.ca 32120 at /newsroom /newsroom/channels/news/simluated-patient-study-sheds-new-light-antibiotic-use-india-262354 <p><strong><em>黑料不打烊 Newsroom</em></strong></p> <p><em>As a result of the overuse or misus<span>e of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world鈥檚 largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.</span></em></p> Wed, 24 Aug 2016 01:43:10 +0000 nima.adibpour@mail.mcgill.ca 26101 at /newsroom /newsroom/channels/news/experts-world-tb-day-2016-march-24-259831 <p><a href="http://www.stoptb.org/events/world_tb_day/">World TB Day</a> is held each year on March 24th and aims to build public awareness for tuberculosis. A disease which despite being curable, remains a destructive epidemic in much of the world.</p> Tue, 22 Mar 2016 14:17:18 +0000 vincent.allaire@mcgill.ca 25540 at /newsroom /newsroom/channels/news/5m-malaria-tuberculosis-drug-discovery-research-257396 <p>University of Toronto and 黑料不打烊 University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases聽 -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.</p> Thu, 17 Dec 2015 20:34:42 +0000 nima.adibpour@mail.mcgill.ca 25046 at /newsroom /newsroom/channels/news/world-tuberculosis-day-march-24-243715 Fri, 20 Mar 2015 19:37:11 +0000 melody.enguix@mcgill.ca 22311 at /newsroom /newsroom/channels/news/tb-avoiding-and-subverting-immunity-240880 Mon, 22 Dec 2014 21:44:23 +0000 melody.enguix@mcgill.ca 21768 at /newsroom /newsroom/channels/news/clerk-pai-named-rsc%E2%80%99s-college-new-scholars-238926 Tue, 16 Sep 2014 17:04:07 +0000 christopher.chipello@mcgill.ca 21139 at /newsroom /newsroom/channels/news/tb-cattle-vaccine-takes-small-step-forward-219685 <p>Scientists have announced a small but important step in the development of an effective cattle vaccine to prevent bovine tuberculosis. They have identified a "biomarker" using sophisticated molecular technology that allows them to predict vaccine efficacy. David Williams, chairman of the Badger Trust, which strongly supports vaccination of both cattle and badgers, said: "We welcome this refinement in laboratory technique, part of the progress towards the long-awaited goal of an effective cattle vaccine.</p> Tue, 08 Jan 2013 21:38:03 +0000 laurie.devine@mcgill.ca 16019 at /newsroom